Johnson & Johnson (NYSE:JNJ) is one of the The 15 Best Stocks to Buy According to Billionaire Ray Dalio.
Johnson & Johnson (NYSE:JNJ) has been in Bridgewater Associates’ 13F portfolio for more than a decade and a half. The fund has maintained a small position in the company since early 2011, increasing this stake to 4.71 million shares at its peak in the second quarter of 2022. It has since trimmed this stake. Filings for the fourth quarter of 2025 show that the fund owned 1.31 million shares of the pharmaceutical, biotechnology and medical technology corporation. This share represents a 23% decrease compared to the previous quarter’s filings. The stock is among Dalio’s top fifteen holdings, according to the 13F portfolio.
READ NEXT: 33 stocks that should double in 3 years.
Johnson & Johnson (NYSE:JNJ) is favored by institutional investors because it has an impressive dividend history dating back more than six decades. The company has a history of dividend growth that has spanned sixty-three years and counting. Since Johnson & Johnson spun off the consumer health business in 2023, hedge funds view the company as a higher-margin, faster-growing company. By focusing solely on innovative medicine and medical technology, JNJ has accelerated its revenue growth. By early 2026, the company forecast sales of $100 billion, surpassing Wall Street estimates. The funds are particularly bullish on blockbuster cancer drug Darzalex, which beat expectations in the fourth quarter of 2025, and new therapy Carvykti, which hit $1 billion in annual sales for the first time.
While we recognize JNJ’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.
READ NEXT: 33 stocks that should double in 3 years and 15 stocks that will make you rich in 10 years
Disclosure: None. Follow Insider Monkey on Google News